Saturday, February 25, 2023 7:52:20 PM
Gio probably all ready know this :) I think I missed the memo when we all agreed to forget that EPIC-SR ever existed (Paxlovid for vaccinated adults without risk factors and vaccinated adults who have a risk factor that was halted by Pfizer due to negative results).
Ps. Already proof Bucillamine will work good with the vax..
pps. but forgot where to find that now lol ... maybe ecomike knows.
PS.. edibles kicking in lol...
I think I missed the memo when we all agreed to forget that EPIC-SR ever existed (Paxlovid for vaccinated adults without risk factors and vaccinated adults who have a risk factor that was halted by Pfizer due to negative results).
— Eric Widera, MD (@EWidera) February 15, 2023
Ps. Already proof Bucillamine will work good with the vax..
pps. but forgot where to find that now lol ... maybe ecomike knows.
PS.. edibles kicking in lol...
Bullish
Recent RVVTF News
- Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures • ACCESS Newswire • 05/20/2026 11:45:00 AM
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
